Summary
- Current Price
- As of today, EOLS price is $7.59, up +2.43% on
- Current Price All-Time High
- EOLS price is currently -80.78% below its historical high of $39.50 set on
- Market Cap
- EOLS current market cap is $501M, up +27.77% over the past 365 days
- Revenue
- EOLS current annual revenue is $297.18M, up +11.61% year-over-year
- Next Earnings
- The next earnings release for EOLS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Evolus, Inc. |
| Ticker | NASDAQ: EOLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | evolus.com |
| Employees | 372 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $7.59 | |
| Price, 1D Change | +2.43% | |
| $501M | ||
| - | ||
| - | ||
| 1.14 | ||
| $297.18M | ||
| Revenue, 1Y Change | +11.61% | |
| -$0.80 | ||
| EPS, 1Y Change | +1.48% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.80 | ||
| EPS Estimate | -$0.09 | N/A |
| EPS Est. Change | +88.76% | N/A |
| $297.18M | ||
| Revenue Estimate | $332.09M | N/A |
| Revenue Est. Change | +11.75% | N/A |
| Current Price | $7.59 | |
| Price Target | $14.00 | - |
| Price Tgt. Change | +84.45% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.27 | -$0.81 | -201.67% | |
| -$0.45 | -$0.80 | -78.00% | |
| -$0.09 | N/A | +88.76% | |
| $0.24 | N/A | +129.96% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $266.10M | $266.27M | +0.07% | |
| $296.47M | $297.18M | +0.24% | |
| $332.09M | N/A | +11.75% | |
| $389.19M | N/A | +30.96% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $7.59 | |
| $5.89 | ||
| $6.49 | ||
| $6.40 | ||
| $6.31 | ||
| $0.11 | ||
| 1.14 | ||
| $0.39 | ||
| 72.25 | ||
| 103.06% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $297.18M | ||
| -$0.80 | ||
| $192.76M | ||
| 64.86% | ||
| -$37.60M | ||
| -12.65% | ||
| -$51.64M | ||
| -17.38% | ||
| -$28.86M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -6.71 | ||
| 1.90 | ||
| 1.54 | ||
| - | ||
| 3 | ||
| -1.76 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 1.58 | ||
| -16.22 | ||
| -59.94 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$23.11M | ||
| $53.83M | ||
| $225.87M | ||
| $142.92M | ||
| $248.97M | ||
| $75.31M | ||
| $155.00M | ||
| $2.53M | ||
| $23.36M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $348.82M | ||
| $230.36M | ||
| $104.41M | ||
| $0.00 | ||
| $8.74M | ||
| $0.00 | ||
| $677.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$42.27M | ||
| -$8.45M | ||
| $17.34M | ||
| $8.45M | ||
| -$50.72M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| BTIG | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Stifel | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Mizuho | → | |
| BTIG | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
No data
Screeners with EOLS
FAQ
- What is the ticker symbol for Evolus, Inc.?
- The ticker symbol for Evolus, Inc. is NASDAQ:EOLS
- Does Evolus, Inc. pay dividends?
- No, Evolus, Inc. does not pay dividends
- What sector is Evolus, Inc. in?
- Evolus, Inc. is in the Healthcare sector
- What industry is Evolus, Inc. in?
- Evolus, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Evolus, Inc. based in?
- Evolus, Inc. is headquartered in United States
- When did Evolus, Inc. go public?
- Evolus, Inc. initial public offering (IPO) was on February 8, 2018
- Is Evolus, Inc. in the S&P 500?
- No, Evolus, Inc. is not included in the S&P 500 index
- Is Evolus, Inc. in the NASDAQ 100?
- No, Evolus, Inc. is not included in the NASDAQ 100 index
- Is Evolus, Inc. in the Dow Jones?
- No, Evolus, Inc. is not included in the Dow Jones index
- When was Evolus, Inc. last earnings report?
- Evolus, Inc.'s most recent earnings report was on August 5, 2026
- When does Evolus, Inc. report earnings?
- The next expected earnings date for Evolus, Inc. is November 4, 2026
Data Sources & References
- EOLS Official Website www.evolus.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1570562/000162828026014001/0001628280-26-014001-index.htm
- EOLS Profile on Yahoo Finance finance.yahoo.com/quote/EOLS
- EOLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/eols
